{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-019829","form_type":"8-K","ticker":"BIAF","cik":"0001712762","company_name":"bioAffinity Technologies, Inc.","filed_at":"2025-10-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.236694+00:00","generated_at":"2026-05-17T01:57:23.133243+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"bioAffinity Technologies announces Australian patent acceptance for lung health platform","bullets":["IP Australia accepted patent application AU 2019253111 for a flow cytometry-based platform to detect multiple lung diseases.","The patent covers methods using fluorescent probes to identify cellular signatures of lung disease in sputum samples.","Patent will be automatically issued in three months unless a third party files an opposition.","Company now holds 18 awarded and 33 pending patents globally, including in the U.S., China, Japan, and Europe.","The technology underpins CyPath® Lung, the company's noninvasive test for early-stage lung cancer."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-019829","json":"https://secwatch.observer/filing/0001493152-25-019829.json","markdown":"https://secwatch.observer/filing/0001493152-25-019829.md","text":"https://secwatch.observer/filing/0001493152-25-019829.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1712762/000149315225019829/0001493152-25-019829-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1712762/000149315225019829/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T01:57:23.133243+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}